Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
10,000+ US Securities
Unlisted Companies not available on US Stock Exchanges
Professionally managed portfolios, designed by Vested’s research team
Get exposure to 50+ countries via global funds managed by the world’s top fund managers
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI). more
| Time Frame | XPH | S&P500 |
|---|---|---|
| 1-Week Return | 0.67% | 1.51% |
| 1-Month Return | 5.98% | 8.24% |
| 3-Month Return | 3.32% | 5.38% |
| 6-Month Return | 19.58% | 7.35% |
| 1-Year Return | 46.61% | 29.5% |
| 3-Year Return | 38.7% | 77.37% |
| 5-Year Return | 22.06% | 75.04% |
| 10-Year Return | 47.2% | 256.12% |
| Time Frame | XPH | S&P500 |
|---|---|---|
| 1-Week Return | 41.65% | 118.47% |
| 1-Month Return | 102.72% | 162.05% |
| 3-Month Return | 14.16% | 23.68% |
| 6-Month Return | 43.71% | 15.47% |
| 1-Year Return | 46.61% | 29.50% |
| 3-Year Return | 11.52% | 21.05% |
| 5-Year Return | 4.07% | 11.85% |
| 10-Year Return | 3.94% | 13.54% |
| Stock name | Ticker | Weight |
|---|---|---|
Organon & Co | OGN | 3.68% |
Corcept Therapeutics Incorporated | CORT | 2.69% |
Axsome Therapeutics Inc | AXSM | 2.47% |
Enliven Therapeutics Inc. | ELVN | 2.39% |
Omeros Corporation | OMER | 2.19% |
Edgewise Therapeutics Inc | EWTX | 2.17% |
Trevi Therapeutics Inc | TRVI | 2.17% |
Perrigo Company PLC | PRGO | 2.09% |
Esperion Therapeutics Inc | ESPR | 2.05% |
Nektar Therapeutics | NKTR | 2.03% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
SPDR® S&P Pharmaceuticals ETF (XPH) share price today is $58.88.
Yes, Indians can buy shares of SPDR® S&P Pharmaceuticals ETF (XPH) on Vested. To buy XPH from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of SPDR® S&P Pharmaceuticals ETF (XPH) on Vested. You can start investing in SPDR® S&P Pharmaceuticals ETF (XPH) with a minimum investment of $1.
The 52-week high price of SPDR® S&P Pharmaceuticals ETF (XPH) is $60.73. The 52-week low price of SPDR® S&P Pharmaceuticals ETF (XPH) is $38.65.
The stock symbol (or ticker) of SPDR® S&P Pharmaceuticals ETF is XPH.
Yes, you can setup SIP in SPDR® S&P Pharmaceuticals ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of XPH on the Vested app.
The expense ratio of SPDR® S&P Pharmaceuticals ETF (XPH) is 0.35%.
Link copied